Kaleb Michauds study from the RA FORWARD registry shows, during the pandemic, significant medication changes (w/o MD consult) or appts. These observations show we were not prepared for this and that Rx suffered. #ACR20 Abstr#L05 https://t.co/vrDd0myGos https://t.co/JFUXItVdRQ

• https://meet.acrconvergence.org/meetings/virtual/ma8N4LDSQ95C3RhDu

Dr Bergman reports on PROs in RCT of upadacitinib versus abatacept in bDMARD-IR RA patients. Greater improvement in PROs with upadacitinib especially in physical functioning, pain, and general health @rheumnow #ACR20 Abstr#1728 https://t.co/NWKrhYAfZn

Smartphone T2T management of RA & SLE is possible. With over 127,316 DAS28 & 42,593 SLEDAI assessments over 2 yrs. T2T was lowest in spring for both, correlating w/ holidays in China. #ACR20 Abstr#1018 https://t.co/bGJtSTDqzo https://t.co/34za6kokOp

• https://meet.acrconvergence.org/meetings/virtual/sG2zZL6AZGibGqTND

SELECT-CHOICE on UPA vs ABA in RA in NEJM Oct 2020. How about PROs? UPA wins in phys fxn, pain, general health over ABA. Abst#1728 @RheumNow #ACR20. ABA better if a safety concern, but this is more evid to go for UPA

#mskus findings in pt w/normal muscle volume(ABC) vs. w/sarcopenia(DEF). This Japanese study showed US of VL muscle is useful in discriminating RA pts w & w/o sarcopenia. @RheumNow #ACR20 abs1537 https://t.co/Gv7V0eebEt

Accdg to this study, no association was found between IFN levels and cognitive function in SLE pts (even after considering factors like SLE dse duration) Interesting! @RheumNow #ACR20 abs1788 @ZahiTouma https://t.co/F4j8H1CWJ9

High-intensity interval training (HIIT) benefits RA, & it looks more than just exercise-FM-CV health. Changes in T cell activity, muscle oxidative metabolism after HIIT in sedentary RA pts n=12 Looking forward to seeing more in this area @dukemedicine #ACR20 ABST1757 @RheumNow https://t.co/5gKheEUYJ6

Our RA patients are susceptible to a dangerous virus which runs rampant, but won't take the vaccine. Why won't patients have their flu shot? @McGillMed 40% hesitant despite public funding. Multiple levels influence; if we don't address, our pts suffer! #ACR20 ABST1740 @RheumNow https://t.co/1Yhr6I2L30